Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain.

Microbiol Spectr · 2022 · PMC9769750 · PMID 36250875

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

During the waning period, the results showed a trend similar to those obtained after the first dose, where relatively low antibody titers resulted in false negativity using the BM and SD assays, particularly in the ChAdOx1 group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.